ESR1 and breast cancer: M10 (non-tumorigenic), MCF-7 (ER+ subtype), MDA-MB-231 (triple-negative subtype), and MDA-MB-468 (highly invasive) cell lines are widely used for breast cancer research, and they represent different subtypes [32, 33].